Grant✓ Small businesses may apply
Bioengineering Partnerships with Industry (U01 Clinical Trial Optional)
National Institutes of Health
- Opportunity #
- PAR-24-325
- Agency
- National Institutes of Health
- ALN (CFDA)
- 93.866, 93.867, 93.286, 93.395, 93.394
- Status
- posted
- Posted
- Nov 6, 2024
- Closes
- Sep 7, 2027
- Funding instrument
- Cooperative Agreement
- Category
- Education, Health
- Cost sharing required
- No
Who can apply
- •Native American tribal governments (Federally recognized)
- •Independent school districts
- •City or township governments
- •Small businesses
- •Public and State controlled institutions of higher education
- •Private institutions of higher education
- •State governments
- •Native American tribal organizations (other than Federally recognized tribal governments)
- •For profit organizations other than small businesses
- •Others (see text field entitled "Additional Information on Eligibility" for clarification)
- •Public housing authorities/Indian housing authorities
- •Special district governments
- •Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
- •County governments
- •Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
Other Eligible Applicants include the following:
Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession.
Synopsis
This Funding Opportunity Announcement (FOA) solicits applications from research partnerships formed by academic and industrial investigators to accelerate the development and adoption of promising bioengineering tools and technologies that can address important biomedical problems. The objectives are to establish these tools and technologies as robust, well-characterized solutions that fulfill an unmet need and are capable of enhancing our understanding of life science processes or the practice of medicine. Awards will focus on supporting multidisciplinary teams that apply an integrative, quantitative bioengineering approach to developing technologies. The goal of the program is to support technological innovations that deliver new capabilities which can realize meaningful solutions within 5 10 years.
Contact
National Institutes of Health · grantsinfo@nih.gov